University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Jeffrey Gelfand, M.D.

Neurologist

Dr. Jeffrey Gelfand is a neurologist at the UCSF Multiple Sclerosis Center where he cares for patients with a wide range of inflammatory neurological disorders, including multiple sclerosis (MS), neurosarcoidosis, optic neuritis, transverse myelitis, neuromyelitis optica, encephalitis, chronic meningitis,paraneoplastic syndromes and neurological manifestations of systemic inflammatory disease. He also co-directs the Autoimmune Encephalopathy Clinic, which is part of the UCSF Memory and Aging Center, and directs the Neuroimmunology Clinic at San Francisco General Hospital. Gelfand's research aims to improve diagnosis and treatment for patients with inflammatory diseases of the central nervous system. He is investigating ways of improving care for patients with neurosarcoidosis. He also studies how the visual system can be used to track disease activity in MS.

Gelfand earned a medical degree at Harvard Medical School. He completed an internship in internal medicine, residency in neurology and fellowship in MS and clinical neuroimmunology at UCSF. He is the recipient of a 2011 American Academy of Neurology clinical research training fellowship and is a two-time winner of the San Francisco Neurological Society's Newman Award. Gelfand is a member of the American Academy of Neurology. He is an assistant professor of neurology at UCSF.

Clinics

Multiple Sclerosis Center
1500 Owens St., Suite 320
San Francisco, CA 94158
Phone: (415) 353-2069
Fax: (415) 353-2633

Hours: Monday to Friday
8:30 a.m. – 4:30 p.m.

More about Jeffrey Gelfand

Education

Harvard School of Medicine 2006

Residencies

UCSF Medical Center, Neurology 2010

Fellowships

UCSF Medical Center, Multiple Sclerosis and Neuroimmunology 2011

Selected Research and Publications

  1. Gelfand JM. Multiple sclerosis: diagnosis, differential diagnosis, and clinical presentation. Handb Clin Neurol. 2014; 122:269-90.
  2. Green AJ, Schwartz D, Gelfand J. Reply: Microcysts in the inner nuclear layer from optic atrophy are caused by retrograde trans-synaptic degeneration combined with vitreous traction on the retinal surface. Brain. 2013 Nov; 136(Pt 11):e261.
  3. Gelfand JM, Cree BA, Nolan R, Arnow S, Green AJ. Microcystic inner nuclear layer abnormalities and neuromyelitis optica. JAMA Neurol. 2013 May; 70(5):629-33.
  4. Gelfand AA, Gelfand JM, Goadsby PJ. Multiple Sclerosis and Related Disorders. Migraine and multiple sclerosis: Epidemiology and approach to treatment. 2013; 2(2):73-79.
  5. Gelfand JM, Green AJ. Reply: Microcystic macular degeneration from optic neuropathy: not inflammatory, not trans-synaptic degeneration. Brain. 2013 Jul; 136(Pt 7):e240.
  6. Boronat A, Gelfand JM, Gresa-Arribas N, Jeong HY, Walsh M, Roberts K, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R, Graus F, Rudy B, Dalmau J. Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels. Ann Neurol. 2013 Jan; 73(1):120-8.
  7. Nolan R, Gelfand JM, Green AJ. Fingolimod treatment in multiple sclerosis leads to increased macular volume. Neurology. 2013 Jan 8; 80(2):139-44.
  8. Saidha S, Sotirchos ES, Ibrahim MA, Crainiceanu CM, Gelfand JM, Sepah YJ, Ratchford JN, Oh J, Seigo MA, Newsome SD, Balcer LJ, Frohman EM, Green AJ, Nguyen QD, Calabresi PA. Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study. Lancet Neurol. 2012 Nov; 11(11):963-72.
  9. Gelfand JM, Goodin DS, Boscardin WJ, Nolan R, Cuneo A, Green AJ. Retinal axonal loss begins early in the course of multiple sclerosis and is similar between progressive phenotypes. PLoS One. 2012; 7(5):e36847.
  10. Gelfand JM, Nolan R, Schwartz DM, Graves J, Green AJ. Microcystic macular oedema in multiple sclerosis is associated with disease severity. Brain. 2012 Jun; 135(Pt 6):1786-93.
  11. Gelfand JM. Neurology Now. Should I see a neurologist for sarcoidosis?. 2012; 1(8):31.
  12. Villoslada P, Cuneo A, Gelfand J, Hauser SL, Green A. Color vision is strongly associated with retinal thinning in multiple sclerosis. Mult Scler. 2012 Jul; 18(7):991-9.
  13. Gelfand AA, Gelfand JM, Prabakhar P, Goadsby PJ. Ophthalmoplegic "migraine" or recurrent ophthalmoplegic cranial neuropathy: new cases and a systematic review. J Child Neurol. 2012 Jun; 27(6):759-66.
  14. Gelfand JM, Cree BA, McElroy J, Oksenberg J, Green R, Mowry EM, Miller JW, Hauser SL, Green AJ. Vitamin D in African Americans with multiple sclerosis. Neurology. 2011 May 24; 76(21):1824-30.
  15. Gelfand JM, Duncan JL, Racine CA, Gillum LA, Chin CT, Zhang Y, Zhang Q, Wong LJ, Roorda A, Green AJ. Heterogeneous patterns of tissue injury in NARP syndrome. J Neurol. 2011 Mar; 258(3):440-8.
  16. Dhand A, Nakagawa K, Nagpal S, Gelfand JM, Kim AS, Smith WS, Tihan T. Cardiac rupture after intravenous t-PA administration in acute ischemic stroke. Neurocrit Care. 2010 Oct; 13(2):261-2.
  17. Gelfand JM, Wintermark M, Josephson SA. Cerebral perfusion-CT patterns following seizure. Eur J Neurol. 2010 Apr; 17(4):594-601.
  18. Gelfand JM, Nelson AB, Fross RD, Glass GA. Speech-activated myoclonus masquerading as stuttering. Neurology. 2009 Jun 2; 72(22):1964.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.